Skip to main content

Table 2 Clinical characteristics of the patients according to the presence or absence of endoscopic Barrett's esophagus.

From: Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease

 

Endoscopic BE

 
 

Negative (n = 94)

Positive (n = 69)

P-value

Patients profiles

   

   Age

   

   median; range (years)

60; 23–80

60; 30–77

0.8825*

   Sex

   

   Female (%)

48 (51.1)

32 (46.4)

0.5542**

   BMI

   

   median; range

24.1; 19.2–39.7

25.8; 19.2–43.6

0.1354*

Endoscopic results

   

   Hiatal hernia (%)

11 (11.7)

30 (43.5)

<0.0001**

   Erosive esophagitis (%)

13 (13.8)

21 (30.4)

0.0099**

Abdominal surface area

   

   VAT (cm2)

97.45 (19.9–514.2)

120.2 (27.6–398.8)

0.0089*

   SAT (cm2)

158.15 (34.5–428.7)

180.4 (35.2–484.8)

0.3169*

Circulating factors secreted from adipocytes

   

   Leptin (ng/mL)

9.45 (2.5–27.6)

12.15 (2.7–26.4)

0.5058*

   Adiponectin (μg/mL)

7.9 (3.2–21.4)

5.6 (3.2–12.5)

0.0089*

Other laboratory parameters

   

   AST (U/L)

24 (12–112)

27 (12–204)

0.0789*

   ALT (U/L)

30 (4–198)

32 (11–258)

0.0645*

   CHE (U/L)

341 (208–719)

372 (198–545)

0.0225*

   HDL (mg/dL)

57 (23–106)

50 (28–93)

0.1158*

   LDL (mg/dL)

125.5 (40–202)

125 (61–241)

0.7548*

   TG (mg/dL)

120 (50–524)

145 (52–809)

0.1076*

   HOMA-R

2.444 (0.578–26.929)

3.184 (1.102–13.743)

0.3538*

  1. *Mann-Whitney U test, **Chi square test.